CD8A and breast cancer: M6A-modifid circATAD2 (hsa_circ_0085465, 333 bp, ATAD2 exon 21-20) functioned as an oncogene in the BC tumorigenesis and participated in the BC immune evasion and CD8+ T cells-mediated immune surveillance through m6A-modification manner.